Pharmaceuticals

What are the latest products in the pipeline of the world’s leading drug companies? How are the pharmaceutical giants and key niche players performing financially – in terms of stock performance, share value, price ratios, etc.? What are the latest deals, alliances and agreements among drug developers and manufacturers? These are just some of the questions answered by the following extensive selection of in-depth pharmaceutical company profiles. Examine the market strategy, organisational structure and product range performance of the likes of Procter & Gamble, Merck & Co, Eli Lilly, Pfizer, GlaxoSmithKline, Novartis and Bayer Schering. Numerous SWOT (Strengths, Weaknesses, Opportunities and Threats) company reports are also listed. Show Less ... more

• Matrixx Initiatives Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  Matrixx Initiatives Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• Migenix Inc.-Detailed Product Pipeline

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Life Science Analytics, Mar 2008 , Pages: 46
  Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones. Scope...

• Ondine Biopharma Corp.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Ondine Biopharma Corp.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• Third Wave Technologies Inc.-Deals & Alliances Report

  EURO€ 461.00USD$ 600.00GBP£ 388.00AUD$ 587.00JPY¥ 59,240.00SEK 3 940,00CHF 566.00CAD$ 611.00 MarketLine, Mar 2008 , Pages: 15
  Third Wave Technologies Inc.-Deals & Alliances Report contains the company’s contact information, business summary, company details, tables, graphs and listings of the number of deals by deal category...

• Kyto BioPharma Inc.-Detailed Product Pipeline

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Life Science Analytics, Mar 2008 , Pages: 9
  Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones. Scope...

• Novo Nordisk A-Detailed Product Pipeline

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Life Science Analytics, Mar 2008 , Pages: 119
  Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones. Scope...

• Carrington Laboratories Inc.-Deals & Alliances Report

  EURO€ 461.00USD$ 600.00GBP£ 388.00AUD$ 587.00JPY¥ 59,240.00SEK 3 940,00CHF 566.00CAD$ 611.00 MarketLine, Mar 2008 , Pages: 18
  Carrington Laboratories Inc.-Deals & Alliances Report contains the company’s contact information, business summary, company details, tables, graphs and listings of the number of deals by deal category...

• Genelabs Technologies Inc.-Deals & Alliances Report

  EURO€ 461.00USD$ 600.00GBP£ 388.00AUD$ 587.00JPY¥ 59,240.00SEK 3 940,00CHF 566.00CAD$ 611.00 MarketLine, Mar 2008 , Pages: 13
  Genelabs Technologies Inc.-Deals & Alliances Report contains the company’s contact information, business summary, company details, tables, graphs and listings of the number of deals by deal category...

• CollaGenex Pharmaceuticals Inc.-Deals & Alliances Report

  EURO€ 461.00USD$ 600.00GBP£ 388.00AUD$ 587.00JPY¥ 59,240.00SEK 3 940,00CHF 566.00CAD$ 611.00 MarketLine, Mar 2008 , Pages: 19
  CollaGenex Pharmaceuticals Inc.-Deals & Alliances Report contains the company’s contact information, business summary, company details, tables, graphs and listings of the number of deals by deal category...

• DJ Orthopedics Inc-Deals & Alliances Report

  EURO€ 461.00USD$ 600.00GBP£ 388.00AUD$ 587.00JPY¥ 59,240.00SEK 3 940,00CHF 566.00CAD$ 611.00 MarketLine, Mar 2008 , Pages: 13
  DJ Orthopedics Inc-Deals & Alliances Report contains the company’s contact information, business summary, company details, tables, graphs and listings of the number of deals by deal category (product,...

• Nastech Pharmaceutical Company, Inc.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 43
  Nastech Pharmaceutical Company, Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company...

• Clinical Data, Inc.-Detailed Product Pipeline

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Life Science Analytics, Mar 2008 , Pages: 41
  Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones. Scope...

• SciClone Pharmaceuticals Inc.-Detailed Product Pipeline

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Life Science Analytics, Mar 2008 , Pages: 46
  Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones. Scope...

• Solbec Pharmaceuticals Ltd.-Detailed Product Pipeline

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Life Science Analytics, Mar 2008 , Pages: 24
  Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones. Scope...

• National Home Health Care Corp-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  National Home Health Care Corp-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures,...

• Roche Holding AG-Detailed Product Pipeline

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Life Science Analytics, Mar 2008 , Pages: 361
  Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones. Scope...

• International Isotopes Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  International Isotopes Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures,...

• CV Therapeutics, Inc.-Detailed Product Pipeline

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Life Science Analytics, Mar 2008 , Pages: 62
  Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones. Scope...

• Immtech Pharmaceuticals, Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Immtech Pharmaceuticals, Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures,...

• Tapestry Pharmaceuticals-Detailed Product Pipeline

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Life Science Analytics, Mar 2008 , Pages: 35
  Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones. Scope...

• StemCells Inc.-Detailed Product Pipeline

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Life Science Analytics, Mar 2008 , Pages: 35
  Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones. Scope...

• Meridian Bioscience Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Meridian Bioscience Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• Carrington Laboratories Inc.-Detailed Product Pipeline

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Life Science Analytics, Mar 2008 , Pages: 49
  Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones. Scope...

• Deltagen Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Deltagen Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market...

• USANA Health Sciences Inc.-Detailed Product Pipeline

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Life Science Analytics, Mar 2008 , Pages: 25
  Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones. Scope...

• Medarex Inc.-Detailed Product Pipeline

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 Life Science Analytics, Mar 2008 , Pages: 123
  Pipeline Reports contain detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones. Scope...

• Stereotaxis Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  Stereotaxis Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• Vicon Fiber Optics Corp.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  Vicon Fiber Optics Corp.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• VIVUS Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  VIVUS Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market...

• Synthetech Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  Synthetech Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market...

• Wendt-Bristol Health Services-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  Wendt-Bristol Health Services-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures,...

• TLC Vision Corp.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  TLC Vision Corp.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• USANA Health Sciences Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  USANA Health Sciences Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• SunLink Health Systems Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  SunLink Health Systems Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures,...

• TriZetto Group Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  TriZetto Group Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends,...

• Tercica Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  Tercica Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market...

• ViroPharma Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  ViroPharma Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market...

• Celsion Corp.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 18
  Celsion Corp.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication...

• Curis Inc.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 36
  Curis Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication...

• Encysive Pharmaceuticals Inc.-Deals & Alliances Report

  EURO€ 461.00USD$ 600.00GBP£ 388.00AUD$ 587.00JPY¥ 59,240.00SEK 3 940,00CHF 566.00CAD$ 611.00 MarketLine, Mar 2008 , Pages: 13
  Encysive Pharmaceuticals Inc.-Deals & Alliances Report contains the company’s contact information, business summary, company details, tables, graphs and listings of the number of deals by deal category...

• Cardiome Pharma Corp.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 30
  Cardiome Pharma Corp.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed...

• CytRx Corp.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 21
  CytRx Corp.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures, dividends, market...

• Ligand Pharmaceuticals Inc.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 39
  Ligand Pharmaceuticals Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products...

• Repligen Corp.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 26
  Repligen Corp.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication...

• EntreMed Inc.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 48
  EntreMed Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication...

• GenVec Inc.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 37
  GenVec Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication...

• Corcept Therapeutics Inc.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 15
  Corcept Therapeutics Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed...

• GelStat Corp.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 14
  GelStat Corp.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication...

• Indevus Pharmaceuticals Inc.-Therapeutic Competitors

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 33
  Indevus Pharmaceuticals Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products...

• North American Scientific Inc.-Financial Company Report

  EURO€ 269.00USD$ 350.00GBP£ 226.00AUD$ 342.00JPY¥ 34,557.00SEK 2 298,00CHF 330.00CAD$ 357.00 Life Science Analytics, Mar 2008 , Pages: 20
  North American Scientific Inc.-Financial Company Report contains the company’s contact information, details, business overview, shares information, stock performance history, price and volume figures,...